Loading organizations...
§ Venture Capital
Ziyuan Capital operates as a private equity firm, concentrating its investments on early-stage companies across China. The firm strategically allocates capital to high-tech enterprises, corporate services providers, and consumer goods businesses. This approach allows Ziyuan Capital to foster growth within diverse, emerging sectors through financial backing and expert guidance.
Established in early 2018, Ziyuan Capital entered the market without publicly named founders in available records. Its inception aligns with the growing private equity landscape in China, seeking to leverage the swift advancements in technology and consumer markets. The firm was strategically positioned to engage with nascent enterprises poised for substantial development within the domestic economy.
Ziyuan Capital supports a varied portfolio of companies primarily within China's new economy sectors. The firm’s core vision is to identify and cultivate innovative businesses, thereby contributing to the evolution of pioneering industries and enhancing overall market dynamism. Ziyuan Capital aims to be a critical partner for companies shaping the next phase of economic advancement.
Ziyuan Capital has 1 tracked investment across 1 company. The latest tracked deal is $13.8M Series A in Hyperway Pharm in April 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 22, 2024 | Hyperway Pharm | $13.8M Series A | — | WAN LEI |